University of Florida
Gainesville, Florida, 32611, United States
NCT Number: NCT01973595
The purpose of this study is to determine whether incorporating almonds into the diets of families with young children will induce beneficial changes in gastrointestinal function, the fecal microbiota profile, and immune and inflammatory processes of the adults and children resulting in improved quality of life. The investigators anticipate finding an increase in beneficial bacteria, improved intestinal function, and decreased inflammation during the almond intervention.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Gainesville, Florida, 32611, United States
This is a randomized, crossover study. After obtaining informed consent, healthy adults aged 18-40 years with children aged 3-6 years will be randomized to either consume almonds and almond paste during the first arm of the study or during the second arm of the study. During the intervention period, adult participants will consume 1.5 ounces of almonds per day, and children will consume 0.5 ounces of almonds per day for 3 weeks. After a 4-week washout period, participants will be crossed to the other treatment (no almond consumption or almond consumption).
Participants will complete daily questionnaires throughout the intervention period, and one week before and after each intervention period. Blood samples will be collected from adults at the baseline and final time points of each intervention. Stool samples will be collected during the pre-baseline and final weeks of each intervention. Dietary intake will be assessed weekly during each intervention period. Gastrointestinal symptoms questionnaires will be completed weekly during each intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
To participate in the study, adult participants must:
Exclusion criteria
To participate in the study, adult and child participants:
Whole, raw almonds with skin, or whole, raw almonds with skin that have been ground into a paste.
No almonds will be consumed by participants for 3 weeks.
Time frame: Baseline #1 (Week 1) to Final #1 (Week 4) of each intervention
The mean of the change between baseline and final time points in stool lactic acid bacteria counts [log(CFU)] was compared for each study arm.
Time frame: Change between Baseline to Week 4
Levels of inflammatory markers in the blood (IL-6) were compared between baseline and final time points once the participants were on the Almonds intervention.. The data were collected at Baseline and Week four.
Time frame: Pre-baseline (Week 0) and Week 3 of each intervention
Changes in average number of stools per week were measured using a Daily Questionnaire. Results were compared between treatment periods for each subject/group.
Time frame: Three week almond intervention vs. three week no almond intervention
Three dietary recalls occurred per study arm, and each recall was scored for quality. The quality scores were averaged per arm and then compared between study arms for each subject/group using the Healthy Eating Index-2010.The Healthy Eating Index assesses diet quality based on 12 components, when summed has maximum points of 100 (HEI scale 0-100).
High component scores indicate intakes close to the recommended ranges or amounts; low component scores indicate less compliance with the recommended ranges or amounts.
National averages total score: children: 54.9 [4-8 years] and adults: 57.4 [31-50 years])
University of Florida
Other
Almonds: Digestive Health and Immune Function of Adults and Children: a Randomized Crossover Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07008586
Behavior, Healthy
Cambridge, United Kingdom
View Trial DetailsNCT06944210
Healthy, Inflammation
Davis, California, United States
View Trial DetailsNCT06041087
Behavior, Bone
Toronto, Ontario, Canada
View Trial DetailsNCT05746845
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Orléans, France
View Trial Details